Virpax Pharmaceuticals (VRPX) Receives FDA Response and Guidance on MMS019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Virpax Pharmaceuticals (VRPX) halted on LUDP
August 18, 2021 9:40 AM EDTVirpax Pharmaceuticals (NASDAQ: VRPX) halted on LUDP
... MoreSmall-cap Virpax (VRPX) Up 100% Today to Push Weekly Gains to Over 500% After Receiving FDA Guidance on SARS and Flu Treatment
August 18, 2021 9:36 AM EDTShares of Virpax Pharmaceuticals (NASDAQ: VRPX) are trading higher after the company said it received a guided response from the US Food and Drug Administration (FDA) concerning its treatment that protects against SARS and flu.
The FDA response brings clarity about MMS019, a... More
Virpax Pharmaceuticals (VRPX) Extends Gain, Now Up 140%
August 18, 2021 7:27 AM EDTVirpax Pharmaceuticals (NASDAQ: VRPX) Extends Gain, Now Up 140%
Virpax Pharmaceuticals (VRPX) Extends Yesterday's Gain, Up Another 65%
August 18, 2021 6:07 AM EDTVirpax Pharmaceuticals (NASDAQ: VRPX) Extends Yesterday's Gain, Up Another 65%
Shares were Up 265% Yesterday... More
